[Research progress in Laggera medicinal plants]

Zhongguo Zhong Yao Za Zhi. 2006 Jul;31(14):1133-40.
[Article in Chinese]

Abstract

This paper reviewed the worldwide research progresses of the genus Laggera both on phytochemical and pharmacological work in the past few decades. The main secondary metabolites of this genus are proved to be sesquitepenoids, flavonoids and phenolic acids. Phamacological investigations revealed that the certain extracts of some Laggera species possess significant bioactivities on anti-inflammation, anti-tumor and anti-viral infection. This review afforded the comprehensive description of the active components as to provide useful references to elucidate their historical clinical application on upper respiratory infection, influenza, parotitis, and recurrent herpes viral infection.

Publication types

  • English Abstract
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal / pharmacology*
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Antineoplastic Agents, Phytogenic / pharmacology
  • Antineoplastic Agents, Phytogenic / therapeutic use
  • Antiviral Agents / pharmacology
  • Antiviral Agents / therapeutic use
  • Flavonoids / chemistry
  • Flavonoids / isolation & purification*
  • Flavonoids / therapeutic use
  • Humans
  • Influenza, Human / drug therapy
  • Molecular Structure
  • Parotitis / drug therapy
  • Phytotherapy
  • Plants, Medicinal / chemistry
  • Ranunculaceae* / chemistry
  • Respiratory Tract Infections / drug therapy*
  • Sesquiterpenes / chemistry
  • Sesquiterpenes / isolation & purification*
  • Sesquiterpenes / therapeutic use

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Antineoplastic Agents, Phytogenic
  • Antiviral Agents
  • Flavonoids
  • Sesquiterpenes